NanoViricides, Inc. (NNVC)

1.25 -0.05 (-3.85%) USD  |  NYAM  |  Dec 12, 15:53
More

NanoViricides Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for NNVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --
Actinium Pharmaceuticals, Inc. --